IP Library Granted Patent US 8,278,467
Granted Patent B2
US 8,278,467 · App. 11/721,858 · Granted Oct 2, 2012

Process and intermediate compounds useful in the preparation of statins

Assignee: REDX Pharma Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,278,467
App. No.
11/721,858
Granted
Oct 2, 2012
Kind
B2
Abstract

There is provides a process for the preparation of a compound of formula (7): wherein R is an optionally substituted hydrocarbyl group or an optionally substituted heterocyclic group; provides that R is not a compound of Formula (a): wherein R a represents an alkyl group, such as a C 1-16 alkyl group, and preferably an isopropyl group; R b represents an aryl group, preferably a 4-fluorophenyl group; R c represents hydrogen, a protecting group or an alkyl group, such as a C 1-16 alkyl group, and preferably a methyl group; and Rd represents hydrogen, a protecting group or a SO 2 R e group where R e is an alkyl group, such as a C 1-16 alkyl group, and preferably a methyl group.

Claims (22)

1. A process for the preparation of a compound of formula (7):

wherein R is one of the following:

and wherein

R 1 is hydrogen, a protecting group or a substituted or unsubstituted hydrocarbyl group;

R 2 is a substituted or unsubstituted acyl group;

R 3 is a substituted or unsubstituted acyl group;

said process comprises:

a) hydroxylating a compound of formula (1):

wherein Y is a halo group, P 1 is hydrogen or a protecting group, and W is ═O or —OP 2 , wherein P 2 is hydrogen or a protecting group, to provide a compound of formula (2):

b) oxidizing the compound of formula (2) to provide a compound of formula (3):

c) coupling the compound of formula (3) with a compound of formula (4):

wherein Z is (PR 11 R 12 ) + X − or P(═O)R 11 R 12 , wherein X is an anion and R 11 and R 12 are each independently an alkyl, aryl, alkoxy or aryloxy group, to provide a compound of formula (5):

wherein when W is —OP 2 , removing at least a portion of the P 2 protecting group and oxidizing the compound of formula (5) to provide a compound of formula (6):

and

d) subjecting the compound of formula (5) when W is ═O, or the compound of formula (6) to ring-opening, removing at least a portion of the P 1 protecting group, and optionally removing at least a portion of additional protecting groups to provide a compound of formula (7).

2. A process for the preparation of a compound of Formula (8):

wherein:

(i) a compound of formula (7), prepared according to claim 1 , is hydrogenated to provide a compound of formula (8);

(ii) a compound of formula (5) prepared according to steps (a) to (c) of claim 2 , is hydrogenated to provide a compound of formula (9):

and when W is —OP 2 , removing the P 2 protecting group and oxidizing the compound of formula (9) to provide a compound of formula (10);

subjecting the compound of formula (9) when W is ═O, or the compound of formula (10) to ring-opening, removing the P 1 protecting group, and optionally removing additional protecting groups to provide a compound of formula (8); or

(iii) a compound of formula (6), prepared according to steps (a) to (c) of claim 2 , is hydrogenated to provide a compound of formula (10) and subjecting the compound of formula (10) to ring-opening, removing the P 1 protecting group, and optionally removing additional protecting groups to provide a compound of formula (8).

Assignments (4)
CHANGE OF NAME Recorded Apr 17, 2015
From: REDX PHARMA LIMITED
To: REDX PHARMA PLC
Reel/Frame 035455/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2011
From: BRADFORD PHARMA LIMITED
To: REDX PHARMA LIMITED
Reel/Frame 027212/0910 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2010
From: PIRAMAL HEALTHCARE UK LIMITED
To: BRADFORD PHARMA LIMITED
Reel/Frame 023994/0394 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 17, 2007
From: MOODY, DAVID JOHN; WIFFEN, JONATHAN WILLIAM
To: NPIL PHARMACEUTICALS (UK) LIMITED
Reel/Frame 020265/0165 →
Priority Claims (1)
GB 0427491.6 · Dec 16, 2004 · national
Continuity (1)
Related Publication 20090312555A1 · Dec 17, 2009